Goldman Sachs Group Inc Treace Medical Concepts, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 665,152 shares of TMCI stock, worth $5.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
665,152
Previous 249,092
167.03%
Holding current value
$5.08 Million
Previous $1.66 Million
132.91%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TMCI
# of Institutions
137Shares Held
39.6MCall Options Held
248KPut Options Held
269K-
Armistice Capital, LLC New York, NY6.2MShares$47.3 Million0.6% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$31 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.27MShares$25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$20.9 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.39MShares$18.3 Million0.04% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $423M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...